Iranian Journal of Radiology

Published by: Kowsar

Diagnostic Efficacy of Perfusion Magnetic Resonance Imaging in Supratentorial Glioma Grading

Seyyed Mohammad Ghodsi 1 , Alireza Khoshnevisan 1 , Mahdi Arjipour 2 , Hossein Ghanaati 3 , Kavous Firouznia 3 , * , Amir Hossein Jalali 3 , Madjid Shakiba 3 and Nafiseh Ghavami 3
Authors Information
1 Department of Neurosurgery, Shariati Hospital, Tehran University of Medical Sciences, Tehran, Iran
2 Department of Neurosurgery, School of Medicine, Hamadan University of Medical Sciences, Hamadan, Iran
3 Advanced Diagnostic and Interventional Radiology Research Center (ADIR), Tehran University of Medical Sciences, Tehran, Iran
Article information
  • Iranian Journal of Radiology: April 2018, 15 (2); e13696
  • Published Online: April 23, 2018
  • Article Type: Research Article
  • Received: May 20, 2017
  • Revised: December 5, 2017
  • Accepted: December 23, 2017
  • DOI: 10.5812/iranjradiol.13696

To Cite: Ghodsi S M, Khoshnevisan A, Arjipour M, Ghanaati H, Firouznia K, et al. Diagnostic Efficacy of Perfusion Magnetic Resonance Imaging in Supratentorial Glioma Grading, Iran J Radiol. 2018 ; 15(2):e13696. doi: 10.5812/iranjradiol.13696.

Abstract
Copyright © 2018, Iranian Journal of Radiology. This is an open-access article distributed under the terms of the Creative Commons Attribution-NonCommercial 4.0 International License (http://creativecommons.org/licenses/by-nc/4.0/) which permits copy and redistribute the material just in noncommercial usages, provided the original work is properly cited
1. Background
2. Objectives
3. Patients and Methods
4. Results
5. Discussion
Acknowledgements
Footnotes
References
  • 1. Ohgaki H, Kleihues P. Epidemiology and etiology of gliomas. Acta Neuropathol. 2005;109(1):93-108. doi: 10.1007/s00401-005-0991-y. [PubMed: 15685439].
  • 2. Di Costanzo A, Pollice S, Trojsi F, Giannatempo GM, Popolizio T, Canalis L, et al. Role of perfusion-weighted imaging at 3 Tesla in the assessment of malignancy of cerebral gliomas. Radiol Med. 2008;113(1):134-43. doi: 10.1007/s11547-008-0232-2. [PubMed: 18338133].
  • 3. Senturk S, Oguz KK, Cila A. Dynamic contrast-enhanced susceptibility-weighted perfusion imaging of intracranial tumors: a study using a 3T MR scanner. Diagn Interv Radiol. 2009;15(1):3-12. [PubMed: 19263367].
  • 4. Tofts PS, Benton CE, Weil RS, Tozer DJ, Altmann DR, Jager HR, et al. Quantitative analysis of whole-tumor Gd enhancement histograms predicts malignant transformation in low-grade gliomas. J Magn Reson Imaging. 2007;25(1):208-14. doi: 10.1002/jmri.20800. [PubMed: 17139631].
  • 5. Pallud J, Mandonnet E, Duffau H, Kujas M, Guillevin R, Galanaud D, et al. Prognostic value of initial magnetic resonance imaging growth rates for World Health Organization grade II gliomas. Ann Neurol. 2006;60(3):380-3. doi: 10.1002/ana.20946. [PubMed: 16983683].
  • 6. Jenkinson MD, Du Plessis DG, Walker C, Smith TS. Advanced MRI in the management of adult gliomas. Br J Neurosurg. 2007;21(6):550-61. doi: 10.1080/02688690701642020. [PubMed: 18071982].
  • 7. Darby DG, Barber PA, Gerraty RP, Desmond PM, Yang Q, Parsons M, et al. Pathophysiological topography of acute ischemia by combined diffusion-weighted and perfusion MRI. Stroke. 1999;30(10):2043-52. doi: 10.1161/01.STR.30.10.2043. [PubMed: 10512905].
  • 8. Schepers J, Veldhuis WB, Pauw RJ, de Groot JW, van Osch MJ, Nicolay K, et al. Comparison of FAIR perfusion kinetics with DSC-MRI and functional histology in a model of transient ischemia. Magn Reson Med. 2004;51(2):312-20. doi: 10.1002/mrm.10691. [PubMed: 14755657].
  • 9. Barajas RJ, Cha S. Benefits of dynamic susceptibility-weighted contrast-enhanced perfusion MRI for glioma diagnosis and therapy. CNS Oncol. 2014;3(6):407-19. doi: 10.2217/cns.14.44. [PubMed: 25438812].
  • 10. Zonari P, Baraldi P, Crisi G. Multimodal MRI in the characterization of glial neoplasms: the combined role of single-voxel MR spectroscopy, diffusion imaging and echo-planar perfusion imaging. Neuroradiology. 2007;49(10):795-803. doi: 10.1007/s00234-007-0253-x. [PubMed: 17619871].
  • 11. Kim YH, Oh SW, Lim YJ, Park CK, Lee SH, Kang KW, et al. Differentiating radiation necrosis from tumor recurrence in high-grade gliomas: assessing the efficacy of 18F-FDG PET, 11C-methionine PET and perfusion MRI. Clin Neurol Neurosurg. 2010;112(9):758-65. doi: 10.1016/j.clineuro.2010.06.005. [PubMed: 20619531].
  • 12. Erdogan C, Hakyemez B, Yildirim N, Parlak M. Brain abscess and cystic brain tumor: discrimination with dynamic susceptibility contrast perfusion-weighted MRI. J Comput Assist Tomogr. 2005;29(5):663-7. doi: 10.1097/01.rct.0000168868.50256.55. [PubMed: 16163039].
  • 13. Lev MH, Ozsunar Y, Henson JW, Rasheed AA, Barest GD, Harsh G, et al. Glial tumor grading and outcome prediction using dynamic spin-echo MR susceptibility mapping compared with conventional contrast-enhanced MR: confounding effect of elevated rCBV of oligodendrogliomas [corrected]. AJNR Am J Neuroradiol. 2004;25(2):214-21. [PubMed: 14970020].
  • 14. Cha S, Tihan T, Crawford F, Fischbein NJ, Chang S, Bollen A, et al. Differentiation of low-grade oligodendrogliomas from low-grade astrocytomas by using quantitative blood-volume measurements derived from dynamic susceptibility contrast-enhanced MR imaging. AJNR Am J Neuroradiol. 2005;26(2):266-73. [PubMed: 15709123].
  • 15. Metellus P, Dutertre G, Mekkaoui C, Nanni I, Fuentes S, Ait-Ameur A, et al. [Value of relative cerebral blood volume measurement using perfusion MRI in glioma management]. Neurochirurgie. 2008;54(4):503-11. doi: 10.1016/j.neuchi.2008.03.007. [PubMed: 18573509].
  • 16. Min ZG, Liu HJ, Li M, Liu LH, Jin CW, Zhang M. [Accuracy of MR perfusion weighted imaging for cerebral glioma grading: a meta-analysis]. Zhonghua Yi Xue Za Zhi. 2010;90(41):2927-31. [PubMed: 21211399].
  • 17. Sun SJ, Qian HF, Li FQ, Li ZY, Wu X. [Diagnostic Value of Combining Permeability with T1 Perfusion Parameters in Quantitative Dynamic Contrast-enhanced Magnetic Resonance Imaging for Glioma Grading]. Zhongguo Yi Xue Ke Xue Yuan Xue Bao. 2015;37(6):674-80. doi: 10.3881/j.issn.1000-503X.2015.06.007. [PubMed: 26725390].
  • 18. Arvinda HR, Kesavadas C, Sarma PS, Thomas B, Radhakrishnan VV, Gupta AK, et al. Glioma grading: sensitivity, specificity, positive and negative predictive values of diffusion and perfusion imaging. J Neurooncol. 2009;94(1):87-96. doi: 10.1007/s11060-009-9807-6. [PubMed: 19229590].
  • 19. Kleihues P, Louis DN, Scheithauer BW, Rorke LB, Reifenberger G, Burger PC, et al. The WHO classification of tumors of the nervous system. J Neuropathol Exp Neurol. 2002;61(3):215-25. discussion 226-9. doi: 10.1093/jnen/61.3.215. [PubMed: 11895036].
  • 20. Asari S, Makabe T, Katayama S, Itoh T, Tsuchida S, Ohmoto T. Assessment of the pathological grade of astrocytic gliomas using an MRI score. Neuroradiology. 1994;36(4):308-10. doi: 10.1007/BF00593267. [PubMed: 8065577].
  • 21. Ludemann L, Grieger W, Wurm R, Budzisch M, Hamm B, Zimmer C. Comparison of dynamic contrast-enhanced MRI with WHO tumor grading for gliomas. Eur Radiol. 2001;11(7):1231-41. doi: 10.1007/s003300000748. [PubMed: 11471617].
  • 22. Law M, Yang S, Wang H, Babb JS, Johnson G, Cha S, et al. Glioma grading: sensitivity, specificity, and predictive values of perfusion MR imaging and proton MR spectroscopic imaging compared with conventional MR imaging. AJNR Am J Neuroradiol. 2003;24(10):1989-98. [PubMed: 14625221].
  • 23. Senft C, Hattingen E, Pilatus U, Franz K, Schanzer A, Lanfermann H, et al. Diagnostic value of proton magnetic resonance spectroscopy in the noninvasive grading of solid gliomas: comparison of maximum and mean choline values. Neurosurgery. 2009;65(5):908-13. discussion 913. doi: 10.1227/01.NEU.0000356982.82378.BA. [PubMed: 19834403].
  • 24. Pronin IN, Holodny AI, Petraikin AV. MRI of high-grade glial tumors: correlation between the degree of contrast enhancement and the volume of surrounding edema. Neuroradiology. 1997;39(5):348-50. doi: 10.1007/s002340050421. [PubMed: 9189880].
  • 25. Direksunthorn T, Chawalparit O, Sangruchi T, Witthiwej T, Tritrakarn SO, Piyapittayanan S, et al. Diagnostic performance of perfusion MRI in differentiating low-grade and high-grade gliomas: advanced MRI in glioma, A Siriraj project. J Med Assoc Thai. 2013;96(9):1183-90. [PubMed: 24163995].
  • 26. Weber MA, Zoubaa S, Schlieter M, Juttler E, Huttner HB, Geletneky K, et al. Diagnostic performance of spectroscopic and perfusion MRI for distinction of brain tumors. Neurology. 2006;66(12):1899-906. doi: 10.1212/01.wnl.0000219767.49705.9c. [PubMed: 16801657].

Featured Image:

Creative Commons License Except where otherwise noted, this work is licensed under Creative Commons Attribution Non Commercial 4.0 International License .

Search Relations:

Author(s):

Article(s):

Create Citiation Alert
via Google Reader

Readers' Comments